Cargando…

Abnormal expression of p53 isoforms can be associated with poor survival in primary breast tumours

Detalles Bibliográficos
Autor principal:	Bourdon, J-C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2008
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3300755/ http://dx.doi.org/10.1186/bcr1936

Ejemplares similares

p53β isoform modulates differentially p53 transcriptional activity in response to stress
por: Fernandes, K, et al.
Publicado: (2008)

D133p53 isoform is a direct p53 target gene that modulates p53 tumour suppressor activity
por: Aoubala, M
Publicado: (2008)

D133P53, directly transactivated by p53, prevents p53-mediated apoptosis without inhibiting p53-mediated cell cycle arrest
por: Aoubala, M, et al.
Publicado: (2010)

p53 isoforms change p53 paradigm
por: Bourdon, JC
Publicado: (2014)

p53 and its isoforms in cancer
por: Bourdon, J-C
Publicado: (2007)

Cytoplasmic p53β Isoforms Are Associated with Worse Disease-Free Survival in Breast Cancer
por: Steffens Reinhardt, Luiza, et al.
Publicado: (2022)

Primary brain tumours following breast cancer
por: Hussain, M, et al.
Publicado: (2015)

Reelin expression in breast tumours is associated with increased survival and is controlled by promoter methylation
por: Stein, T, et al.
Publicado: (2008)

Functional analysis of altered Tenascin isoform expression in breast cancer
por: Alcock, RA, et al.
Publicado: (2006)

p53 mutation, deprivation and poor prognosis in primary breast cancer
por: Baker, L, et al.
Publicado: (2010)

P53. Effect of lymphodepletion and tumour on host and reconstituted regulatory T-cells in a model of murine melanoma
por: Kovács, J, et al.
Publicado: (2014)

Prognostic value genotypes and LOH at TP53 codon 72 and TP53 mutations in primary breast cancer
por: Kyndi, M, et al.
Publicado: (2005)

Expression of novel p53 isoforms in oral lichen planus
por: Ebrahimi, Majid, et al.
Publicado: (2008)

Expression of p53 protein isoforms predicts survival in patients with multiple myeloma
por: Rojas, Elizabeta A., et al.
Publicado: (2022)

Investigation of the role of the p38 MAPK α and δ isoforms in nonresponse to tumour necrosis factor blockade in the synovium of rheumatoid arthritis patients
por: Coulthard, LR, et al.
Publicado: (2007)

RASSF2 can suppress the growth of breast cancer cell lines and is epigenetically inactivated in breast tumours
por: Cooper, WN, et al.
Publicado: (2008)

Expression of Forkhead box P3 isoforms in hepatocellular carcinoma cells
por: Chen, George, et al.
Publicado: (2014)

Characterization of peptide aptamers to the Anterior Gradient 2: a novel inhibitor of the tumour suppressor protein p53
por: Fourtouna, A, et al.
Publicado: (2006)

The Emerging Landscape of p53 Isoforms in Physiology, Cancer and Degenerative Diseases
por: Anbarasan, Thineskrishna, et al.
Publicado: (2019)

Adaptive homeostasis and the p53 isoform network
por: Mehta, Sunali, et al.
Publicado: (2021)

Expression of TP53 Isoforms p53β or p53γ Enhances Chemosensitivity in TP53(null) Cell Lines
por: Silden, Elisabeth, et al.
Publicado: (2013)

Identification and role of migration stimulating factor isoforms in breast carcinomas
por: Schor, AM, et al.
Publicado: (2008)

Effect of p53 and its N‐terminally truncated isoform, Δ40p53, on breast cancer migration and invasion
por: Zhang, Xiajie, et al.
Publicado: (2021)

Are there features on imaging or core biopsy that can predict tumour-positive margins after breast-conserving surgery?
por: Hill, N, et al.
Publicado: (2010)

Increased p53 protein content of colorectal tumours correlates with poor survival.
por: Remvikos, Y., et al.
Publicado: (1992)

Expression of wild-type and mutated TP53 in breast carcinomas
por: Baumbusch, LO, et al.
Publicado: (2005)

Cellular localization of the proto-oncogenic p53 inhibitor AGR2 protein in breast cancer
por: Fourtouna, A, et al.
Publicado: (2008)

p53 Protein Isoforms: Key Regulators in the Front Line of Pathogen Infections?
por: Terrier, Olivier, et al.
Publicado: (2013)

Regulation of cytochrome P450s in breast cancer and their role for tumour growth and anticancer chemotherapy
por: Friedberg, T, et al.
Publicado: (2006)

The RNA helicase p68 modulates expression and function of the Δ133 isoform(s) of p53, and is inversely associated with Δ133p53 expression in breast cancer
por: Moore, Hayley C, et al.
Publicado: (2010)

Structural effect of P278A mutation conferring breast cancer susceptibility in the p53 DNA-binding core domain
por: Suneetha, Y, et al.
Publicado: (2012)

p53 Dysregulation in Breast Cancer: Insights on Mutations in the TP53 Network and p53 Isoform Expression
por: Steffens Reinhardt, Luiza, et al.
Publicado: (2023)

MDM2-dependent inhibition of P53 is required for Epstein-Barr virus B cell growth transformation and infected cell survival
por: Forte, E, et al.
Publicado: (2009)

The in vivo function of the p53 target gene TIGAR
por: Cheung, Eric C, et al.
Publicado: (2012)

Abnormal accumulation of p53 predicts radioresistance leading to poor survival in patients with endometrial carcinoma
por: Akiyama, Azusa, et al.
Publicado: (2019)

A TRAIL-R1-specific ligand in combination with doxorubicin selectively targets primary breast tumour cells for apoptosis
por: Twiddy, D, et al.
Publicado: (2010)

Alterations in the p53 isoform ratio govern breast cancer cell fate in response to DNA damage
por: Steffens Reinhardt, Luiza, et al.
Publicado: (2022)

Abnormalities in primary cilium of osteoblasts of adolescent idiopathic scoliosis patients
por: Oliazadeh, N, et al.
Publicado: (2015)

Gene expression profiles and the TP53 mutation status are powerful prognostic markers of breast cancer
por: Langerød, A, et al.
Publicado: (2005)

p53, a novel regulator of lipid metabolism pathways
por: Goldstein, Ido, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_v2q9ohr9phvsv1r29de75dqsq7